Lord Drayson, Minister of State for Science and Innovation, yesterday officially opened UCB’s new 55,900 sq ft ‘Biologics R&D Centre’ at the Slough Trading Estate.
The three storey building, located on Ajax Avenue represents an investment of £25m and will be primarily used for the discovery and early development of therapeutic antibodies.
UCB, an occupier at the Estate since 1980 (as Celltech), is the fourth largest investor in UK pharmaceutical research and development, and expects the centre to accommodate 100 scientists over the next few years.
Kevin O’Connor, regional director of Slough Trading Estate, said: ‘Having been an occupier for nearly 30 years, we are delighted that UCB has selected the Trading Estate as the location of this groundbreaking new facility.
UCB’s investment is a clear demonstration of Slough’s continued, and growing, attraction for world class businesses.’